Clinical Trial as Monidor Expands into Remote Patient Monitoring

19.11.2024

Background and need

During the Covid19 pandemic, hospitals faced unprecedented challenges to adapt. Monidor remote IV therapy monitoring was quickly adopted in inpatient wards and proved to be a valuable tool to support healthcare professionals. But this raised a new question: could the same remote monitoring be used to monitor oxygen saturation, pulse and other vital signs?

Discussions with over a hundred nurses and fifty doctors revealed a clear need - spot monitoring of vital signs was simply not enough. This need led us to develop an easy-to-use and lightweight solution for remote monitoring of vital signs.

Study

In the summer of 2024, we conducted a clinical study at Department 4A of Savonlinna Central Hospital, where we verified the safety and functionality of the new remote monitoring of vital signs in a hospital environment.

The study included 30 adult patients with respiratory diseases such as pulmonary infection, COPD exacerbation or pulmonary embolism. Each patient's oxygen saturation and pulse rate were monitored remotely for about 24 hours. The results were excellent: the alarms worked accurately and the software was found to be safe for use in inpatient settings.

We asked the nurses involved in the study how remote monitoring affected patient safety. 94% of respondents felt it improved safety, with the remainder rating the impact as neutral. This feedback is very valuable to us and shows that Monidor remote monitoring provides important additional support for healthcare.

 

Our development work continues and we are committed to delivering solutions that make the work of healthcare staff easier and patient safety even more effective.

Our clinical trial-proven remote monitoring software will be released shortly in 2024, upon completion of its MDR medical device certification.